Tilray Brands TLRY
NASDAQ TLRY
$4.68 -0.15 (-3.11%)
As of: Aug 20, 2026 · 3:59 PM EDT

Tilray Brands (TLRY) Depreciation & Amortization (CF) (2017 - 2022)

Tilray Brands' (TLRY) quarterly Depreciation & Amortization (CF) came in at $34.1 million in Q3 2022, down 13.38% YoY from $39.3 million in Q3 2021, and down 16.43% on a QoQ basis from $40.8 million in Q2 2022.

Tilray Brands (TLRY) Depreciation & Amortization (CF) (2017 - 2022) Analysis & Trends

Tilray Brands (TLRY) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $34.1 million in Q3 2022.

  • Quarterly Depreciation & Amortization (CF) fell 13.38% year-over-year to $34.1 million in Q3 2022, while the trailing twelve-month figure through May 2023 was $34.1 million (down 77.96% YoY) and the FY2022 annual result came in at $154.6 million, up 127.9% from the prior year.
  • Depreciation & Amortization (CF) declined to $34.1 million in Q3 2022, from $40.8 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $40.8 million in Q2 2022 to a low of $479000.0 in Q1 2018.
  • A 5-year average of $16.7 million and a median of $11.5 million in 2020 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2018 — Depreciation & Amortization (CF) jumped 552.55% — and 2022, when it declined 13.38%.
  • Tracing TLRY's Depreciation & Amortization (CF) over 5 years: stood at $2.9 million in 2018, then soared by 113.35% to $6.3 million in 2019, then soared by 91.61% to $12.0 million in 2020, then jumped by 211.45% to $37.5 million in 2021, then slipped by 9.08% to $34.1 million in 2022.
  • The last three Depreciation & Amortization (CF) figures came in at $34.1 million (Q3 2022), $40.8 million (Q2 2022), and $37.0 million (Q1 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 241.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 119.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 1.02 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 24.20 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 672.30 Mn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 171.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Tilray Brands 523.93 Mn 289.30 Mn 90.52 Mn -

Historic Data

Download Data
DateValue
Aug 31, 2022 34.07 Mn
Aug 31, 2022 34.07 Mn
May 31, 2022 40.77 Mn
May 31, 2022 40.77 Mn
Feb 28, 2022 37.02 Mn
Feb 28, 2022 37.02 Mn
Nov 30, 2021 37.47 Mn
Nov 30, 2021 37.47 Mn
Aug 31, 2021 39.33 Mn
Aug 31, 2021 39.33 Mn
May 31, 2021 24.54 Mn
May 31, 2021 24.54 Mn
Nov 30, 2020 12.03 Mn
Nov 30, 2020 12.03 Mn
Aug 31, 2020 10.98 Mn
Aug 31, 2020 10.98 Mn
May 31, 2020 25.21 Mn
May 31, 2020 25.21 Mn
Mar 31, 2020 4.56 Mn
Mar 31, 2020 4.56 Mn